Date published: 2026-4-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

DAP-5 Activators

DAP-5 activators encompass a variety of chemical compounds that indirectly stimulate the functional activity of DAP-5 through intricate cellular signaling pathways. Forskolin and IBMX, for instance, play pivotal roles in elevating intracellular cAMP, which in turn activates PKA – a kinase with the potential to phosphorylate and enhance DAP-5 activity. Similarly, PMA, as a PKC activator, and Ionomycin, through its role as a calcium ionophore, can initiate signaling cascades that lead to the phosphorylation and subsequent activation of DAP-5. These phosphorylation events are critical, as Okadaic Acid, an inhibitor of protein phosphatases.

DAP-5 Activators are a diverse array of chemical compounds that enhance the functional activity of DAP-5 through modulation of specific signaling pathways and biological processes. Among these activators, Forskolin, by increasing intracellular cAMP, activates protein kinase A (PKA), which could potentially phosphorylate and enhance the activity of DAP-5. Similarly, IBMX, which inhibits the breakdown of cyclic nucleotides, sustains PKA activity, thus contributing to the activation of DAP-5. Phorbol 12-myristate 13-acetate (PMA), known to activate protein kinase C (PKC), and Ionomycin, a calcium ionophore, can stimulate calcium-dependent kinases that may lead to the activation of DAP-5 through phosphorylation events. The inhibition of protein phosphatases by Okadaic Acid results in the prolongation of phosphorylated states of proteins, which can indirectly result in the enhanced activity of DAP-5 In the cellular milieu, the modulation of ion channels by compounds such as Spermine can indirectly influence the activity of DAP-5 by altering ion homeostasis. Epigallocatechin gallate (EGCG) affects kinase activity, which can shift signaling networks towards the activation of DAP-5. Targeted inhibition of phosphoinositide 3-kinases by LY294002 may enhance DAP-5 activity through feedback mechanisms. Similarly, PD98059, a MEK inhibitor, can lead to the activation of alternative pathways that upregulate DAP-5 activity. A23187, another calcium ionophore, supports the hypothesis that calcium-dependent signaling pathways are integral to the activation of DAP-5. Sphingosine-1-phosphate signals through G-protein-coupled receptors and could enhance DAP-5 activity via downstream effectors. Lastly, Staurosporine, though a broad kinase inhibitor, at precise concentrations may selectively inhibit kinases that suppress DAP-5 activity, thereby indirectly enhancing its function. Collectively, these compounds contribute to a complex network of biochemical events that result in the functional activation of DAP-5.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

D-erythro-Sphingosine-1-phosphate can activate sphingosine-1-phosphate receptors, which are coupled to G-proteins, leading to downstream signaling events that may enhance the activity of DAP-5.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a broad-spectrum kinase inhibitor, but at low concentrations, it can selectively inhibit certain kinases, potentially relieving inhibition on pathways activating DAP-5.